Brian T. David, Ph.D.
Affiliations: | 2009 | University of California, Irvine, Irvine, CA |
Google:
"Brian David"Mean distance: 15.75 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorOswald Steward | grad student | 2009 | UC Irvine | |
(Bladder control following spinal cord injury.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Metcalfe M, David BT, Langley BC, et al. (2023) Elevation of NAD by nicotinamide riboside spares spinal cord tissue from injury and promotes locomotor recovery. Experimental Neurology. 114479 |
Raue KD, David BT, Fessler RG. (2022) The spinal cord-gut-immune axis and its implications on therapeutic development for spinal cord injury. Journal of Neurotrauma |
Platt A, David BT, Fessler ARG. (2020) Stem Cell Clinical Trials in Spinal Cord Injury: A Brief Review of Studies in the United States. Medicines (Basel, Switzerland). 7 |
Trawczynski M, Liu G, David BT, et al. (2019) Restoring Motor Neurons in Spinal Cord Injury With Induced Pluripotent Stem Cells. Frontiers in Cellular Neuroscience. 13: 369 |
David BT, Sampath S, Dong W, et al. (2014) A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury. Journal of Neurotrauma. 31: 1800-6 |
David BT, Ratnayake A, Amarante MA, et al. (2013) A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiology of Disease. 54: 194-205 |
David BT, Steward O. (2010) Deficits in bladder function following spinal cord injury vary depending on the level of the injury. Experimental Neurology. 226: 128-35 |